Substituted aliphatic amine-containing macrocyclic immunomodulators
    3.
    发明授权
    Substituted aliphatic amine-containing macrocyclic immunomodulators 失效
    取代的含脂肪胺的大环免疫调节剂

    公开(公告)号:US5457194A

    公开(公告)日:1995-10-10

    申请号:US99976

    申请日:1993-07-30

    CPC分类号: C07D498/18

    摘要: Compounds having the formula ##STR1## and the pharmaceutically acceptable salts, esters, amides and prodrugs thereof, wherein one of R.sup.104 and R.sup.105 is hydrogen, and the other of R.sup.104 and R.sup.105 is a radical having the formula ##STR2## as well as pharmaceutically compositions containing such compounds and methods of immunomodulative therapy utilizing the same.

    摘要翻译: 具有式(I)的化合物及其药学上可接受的盐,酯,酰胺和前药,其中R104和R105中的一个是氢,R104和R105中的另一个是具有下式的基团(II )以及含有这些化合物的药物组合物和利用其的免疫调节治疗方法。

    Substituted alicyclic-aliphatic amine-containing macrocyclic
immunomodulators
    7.
    发明授权
    Substituted alicyclic-aliphatic amine-containing macrocyclic immunomodulators 失效
    取代的脂环族脂肪族胺的大环免疫调节剂

    公开(公告)号:US5561139A

    公开(公告)日:1996-10-01

    申请号:US419784

    申请日:1995-04-11

    CPC分类号: C07D498/18

    摘要: Compounds having the formula ##STR1## and the pharmaceutically acceptable salts, esters, amides and prodrugs thereof, wherein one of R.sup.104 and R.sup.105 is hydrogen, and the other of R.sup.104 and R.sup.105 is a radical having the formula ##STR2## as well as pharmaceutically compositions containing such compounds and methods of immunomodulative therapy utilizing the same.

    摘要翻译: 具有式(I)的化合物及其药学上可接受的盐,酯,酰胺和前药,其中R104和R105中的一个是氢,R104和R105中的另一个是具有下式的基团(II )以及含有这些化合物的药物组合物和利用其的免疫调节治疗方法。

    Substituted alicyclic aliphatic-amine containing macrocyclic
immunomodulators
    9.
    发明授权
    Substituted alicyclic aliphatic-amine containing macrocyclic immunomodulators 失效
    取代的脂环族脂族胺含大环免疫调节剂

    公开(公告)号:US5530120A

    公开(公告)日:1996-06-25

    申请号:US343266

    申请日:1994-11-21

    CPC分类号: C07D498/18

    摘要: Compounds having the formula ##STR1## and the pharmaceutically acceptable salts, esters, amides and prodrugs thereof, wherein one of R.sup.104 and R.sup.105 is hydrogen, and the other of R.sup.104 and R.sup.105 is a radical having the formula ##STR2## as well as pharmaceutically compositions containing such compounds and methods of immunomodulative therapy utilizing the same.

    摘要翻译: 具有式(I)的化合物及其药学上可接受的盐,酯,酰胺和前药,其中R104和R105中的一个是氢,R104和R105中的另一个是具有下式的基团(II )以及含有这些化合物的药物组合物和利用其的免疫调节治疗方法。